C
US self-pay prices

CoraDoc GLP-1 prices

Compounding

Compounded semaglutide and tirzepatide programs paid once for 6 weeks to 12 months, with no subscription; separate programs for new patients and for maintenance. CoraDoc has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide from $77/mo; Compounded tirzepatide from $127/mo. Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.

2 offers · US self-pay · 0 maintenance quotes

  • Compounded semaglutide via CoraDoc

    Semaglutide · Compounded

    Compounded · Not FDA-approved
    Advertised pricefrom $77/mo

    12-month upfront payment required

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: 12-month new-patient program paid once ($924); 6 weeks $299, 3 months $495, 6 months $522; maintenance programs $129 to $199 a month by length ($1,548 for 12 months); provider visits, shipping and supplies included; no subscription

    Weekly injection. CoraDoc's own pages disagree on the 6-month price ($522 on the product page, $595 on its homepage and blog) and on maintenance (some posts say a flat $199 at any dose). Its refund policy charges a $100 fee and allows no refund once the medication is compounded or shipped. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source
  • Compounded tirzepatide via CoraDoc

    Tirzepatide · Compounded

    Compounded · Not FDA-approved
    Advertised pricefrom $127/mo

    12-month upfront payment required

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: 12-month new-patient program paid once ($1,524); 6 weeks $399, 3 months $695, 6 months $822; maintenance programs $229 to $299 a month by length ($2,748 for 12 months); provider visits, shipping and supplies included; no subscription

    Weekly injection. Its homepage and blog list the 6-month program at $894 rather than $822. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Questions

CoraDoc GLP-1 cost: common questions

How much does semaglutide cost through CoraDoc?

Compounded semaglutide: from $77/mo (12-month new-patient program paid once ($924); 6 weeks $299, 3 months $495, 6 months $522; maintenance programs $129 to $199 a month by length ($1,548 for 12 months); provider visits, shipping and supplies included; no subscription). Checked Oct 17, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.

How much does tirzepatide cost through CoraDoc?

Compounded tirzepatide: from $127/mo (12-month new-patient program paid once ($1,524); 6 weeks $399, 3 months $695, 6 months $822; maintenance programs $229 to $299 a month by length ($2,748 for 12 months); provider visits, shipping and supplies included; no subscription). Checked Oct 17, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.

Does CoraDoc offer FDA-approved GLP-1 medication or compounded versions?

The CoraDoc offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.

When were CoraDoc prices last checked?

Each quote carries its own check date and links the page it was read from: Oct 17, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.